Inpatient Admissions and Re-Admissions in Medicare Beneficiaries Initiating Umeclidinium/Vilanterol or Tiotropium Therapy.
Michael BogartGary Yat-Hung LeungAnissa CyhaniukKristi K DiRoccoPublished in: International journal of chronic obstructive pulmonary disease (2024)
Patients with COPD using Medicare in the US and receiving UMEC/VI or TIO reported similar time-to-first inpatient admission and similar proportion of re-admissions.